OTLK — OUTLOOK THERAPEUTICS INC

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

Trend Edge Setup Score

Trend Edge rates OTLK Bearish with a Setup Score of 49, net conviction 29, actionability 83. How the Setup Score works →

Total Setup Score49
Directional BiasBearish
Net Conviction29
Actionability83 (in range)

Key signals behind this score

About OUTLOOK THERAPEUTICS INC

Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic bevacizumab product formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$1.45
Market Cap$215M
Float96.4M
Shares Outstanding148.6M
P/E (Forward)2.85
Price/Sales (TTM)646.73
vs. Analyst Target+279.3% to analyst PT
Operating Margin (TTM)-11006.82%
Revenue (TTM)$333,141
Dividend RateNone
Analyst Target Price$5.50 (6 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $5.9M -$35.2M -$554,069 -$36.2M
2021 N/A -$53.2M -$262,139 -$51.5M
2022 N/A -$66.1M -$204,694 -$64.4M
2023 N/A -$59.0M -$44,188 -$57.4M
2024 $170,124 -$75.4M -$113,859 -$72.1M
2025 $1.4M -$62.4M $657,205 -$63.6M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $1.5M -$20.2M
Sep 2025 -$91,787 -$13.3M
Dec 2025 -$1.2M -$23.1M
Mar 2026 $127,439 -$4.5M

Ownership & Float

Insider Ownership17.4%
Institutional Ownership6.9%
Short Float14.1%

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$0.85Near-term / short-term trend
Weekly40-Week SMA$0.90Medium-term trend
Weekly80-Week SMA$1.30Cyclical trend (business cycle)
Weekly200-Week SMA$9.35Secular trend (multi-year)
Monthly10-Month SMA$0.97Near-term monthly trend
Monthly20-Month SMA$1.26Medium-term monthly trend
Monthly40-Month SMA$6.60Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$0.80 support 2.25x 0 months ago
$0.30 support 4.31x 1 months ago
$1.90 resistance 4.05x 10 months ago
$5.80 resistance 5.14x 19 months ago

Historical Earnings Reactions

TimeframeAvg ReturnMedianWin RateBestWorst
Gap N/A N/A N/A N/A N/A
1 Day N/A N/A N/A N/A N/A
1 Week N/A N/A N/A N/A N/A
2 Weeks N/A N/A N/A N/A N/A
1 Month N/A N/A N/A N/A N/A

Next earnings: August 13, 2026 (40 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan3.3%60.0%10
Feb14.0%40.0%10
Mar-9.5%30.0%10
Apr-7.3%50.0%10
May33.1%70.0%10
Jun7.6%40.0%10
Jul4.2%60.0%10
Aug-17.9%30.0%10
Sep4.9%50.0%10
Oct17.7%50.0%10
Nov-10.3%20.0%10
Dec-10.7%30.0%10

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.01% 43.3% 471
Tuesday 0.00% 43.5% 520
Wednesday -0.62% 43.2% 518
Thursday 0.09% 42.1% 508
Friday 0.91% 47.2% 508

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 6.9%

Insider Transactions — Smart Summary

Total insider ownership: 17.4%

12-Month Insider Activity Summary

Total Filings6
Net Value+N/A
Net Shares Change9,129,883
% of Float9.5%
C-Suite Filings0
Clusters Detected1

Key Insiders

NameTitleNet ValueFilingsActivity
Sukhtian Ghiath M. +$5.0M 1 1 buy
HILZINGER KURT J +$176,520 1 1 buy
Sukhtian Faisal Ghiath +$50,005.818 1 1 buy
Haddadin Yezan Munther +$39,105.4 2 2 buy
THURMAN RANDY H +$2,145 1 1 buy

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2026-05-27 – 2026-06-03 6 5 +$5.3M

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-06-01 Sukhtian Ghiath M. +$5.0M Transaction at $0.59, now +147.7%
2026-06-03 Haddadin Yezan Munther +$24,145.4 Transaction at $0.83, now +74.2%
2026-05-27 THURMAN RANDY H +$2,145 Transaction at $0.43, now +238.0%
2026-05-27 Sukhtian Faisal Ghiath +$50,005.818 Transaction at $0.41, now +254.3%
2026-05-27 Haddadin Yezan Munther +$14,960 Transaction at $0.44, now +229.5%
2026-05-27 HILZINGER KURT J +$176,520 Transaction at $0.44, now +228.6%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for OUTLOOK THERAPEUTICS INC (OTLK) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for OTLK on Trend Edge →